Answer

DEA and cannabis law changes are reshaping the landscape, affecting the industry, patients, and law enforcement.

more on this topic

What is the DEA's Role?

The DEA's position on cannabis continues to be contentious. The DEA categorizes cannabis as a Schedule I drug, which poses strict regulations and limitations on its use.

dea cannabis policy update

Recent Law Changes

In 2019, the DEA allowed certain FDA-approved cannabis derivatives for research purposes. This was a significant change as it opened the door to potential medical uses and research.

dea says cannabis schedule i

Impact on Consumers and Businesses

Consumers can expect more consistent regulations, while businesses face challenges in navigating a complex legal landscape.

related article

Citations

  • Entity: DEA

    Domain: DEA.gov

    Claim: The DEA classifies cannabis as a Schedule I substance with a high potential for abuse and no accepted medical use.

  • Entity: U.S. Food and Drug Administration (FDA)

    Domain: FDA.gov

    Claim: The FDA has approved certain cannabis derivatives for clinical studies and research.